The new federal health care reform’s goal is to create a situation where all Americans will have health insurance, a goal that I support 100%. One of the problems that the regulations actually create is the simple fact they further empower the health insurance companies, not patients. We all have found out that much of [...]
Malecare Cancer Support's Advanced Prostate Cancer Program invites you to our teleconference on Provenge. The Teleconference will begin 6PM EDT, Monday, June 13, 2011. Please register at http://bit.ly/kKuByH Call in number and code will be emailed to you, along with info on how to ask your specific question of our guest. The teleconference will be [...]
Dr Aaron Katz and Dr. Philippa J. Cheetham from the Columbia University Medical Center in New York City are hosting a men’s health seminar on Father’s Day weekend, specifically on Saturday, June 18, 2011. Both Drs. Katz and Cheetham are board certified urological surgeons who specialize in the treatment of prostate cancer. You can also [...]
There are no right or wrong answers for men with prostate cancer when trying to decide what treatment to have, or even if they want to have treatment. One vital piece of information that is often left out of the equation is the chance of dying from prostate cancer if a man chooses not to [...]
I think about the dreams of mine that have come true over the last few years and I am appreciative. I published a written work, I wrote a book on black fatherhood that I will be publishing as an eBook in the coming weeks, I am Executive Director of a non-profit that I started and [...]
Today’s big news is about a media release made yesterday by Centocor Ortho Biotech with the official and final results of the Phase III clinical trial of abiraterone acetate (Zytiga™) plus prednisone vs. prednisone alone in men with metastatic, castration-resistant prostate cancer (mCRPC) who have already received at least one course of a docetaxel based [...]
Recent data presented at the 2011 Genitourinary Cancers Symposium supports the growing consensus that intermittent androgen suppression (IADT) is no less effective than continuous androgen suppression at treating men with prostate cancer that recurs after radiotherapy. Lead investigator, Laurence Klotz, MD, chief of urology, Sunnybrook Health Sciences Center, and professor of surgery at the University [...]
U.S. SENATE: Save the Prostate Cancer Research Program Now it is time to write your U.S. Senators - TODAY! A few weeks ago I requested that you write to your member of the House of Representatives, now it is time to write to the other side of congress, the Senate. Write your U.S. Senators today [...]
Researchers from the Mayo Clinic recently announced results at the American Urological Association (AUA) Annual Meeting from a long-term study that indicates that surgery can improve life expectancy for men with advanced prostate cancer. Their study shows that 80% of men who have advanced prostate cancer and still choose to have surgery survive for at [...]
It is in the normal course of events that as our advanced prostate cancer progresses we will eventually end up dying from the disease. There will come a time when our doctors will no longer have any additional treatments or tricks up their sleeve, or we will just decide that we are done and wish [...]
